Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
Date:11/11/2008

ent ratio of 6.4 to 1 and $12.4 million in cash and cash equivalents on September 30, 2008. The Company had Stockholders' Equity of $35.1 million, with total assets of $38.5 million versus total liabilities of $3.4 million. For the first three months of fiscal year 2009, the Company generated $0.5 million in cash from operations versus $1 million for the same period in 2008.

Business Development

Tianyin has received approval from the Chinese State Food and Drug Administration (SFDA) to produce Laonian Kechuan Tablets in the dosage form of 0.25 gram/tablet (SFDA approval number Z20083360) and Fuke Zhidai Tablets in the dosage form of 0.4 gram/tablet (SFDA approval number Z20083375). Laonian Kechuan Tablets is a TCM drug that effectively treats asthma in people aged 60 or above. Fuke Zhidai Tablets is a TCM drug used to treat abnormal leucorrhea, which is caused by chronic cervicitis, endometritis and endocolpitis. The Company plans to launch Laonian Kechuan Tablets and Fuke Zhidai Tablets in the domestic market and begin recording revenue in November 2008 and December 2008, respectively. The Company launched the production of Azithromycin Dispersible Tablets in August 2008 and is due to market the new product in October 2008. Azithromycin is highly effective in treating upper and lower respiratory tract infections and other bacterial infections in the skin and reproductive system. Tianyin received approval from the Chinese State Food and Drug Administration (SFDA) to produce Azithromycin Dispersible Tablets in December 28, 2007.

Tianyin continues to invest in information systems and post-marketing studies and monitoring to improve efficiency. The Company is also making progress constructing the plant they started building in the end of April 2008. Also, Tianyin continues to evaluate acquisition opportunities which will complement the existing product and manufacturing lines, as well as provide accretive earnings growth.

Tianyin's common st
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
2. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
3. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
4. Tianyin Pharmaceutical Appoints Three New Independent Board Members
5. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
6. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
7. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
8. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
9. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
10. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
11. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 SoundConnect , an award ... to announce that Darren Suders has joined the team ... will drive the partner program through innovative ... , Darren brings more than 10-years of channel ... in channel operations, from policy development, to partner education ...
(Date:11/26/2014)... 2014 Deep Research Report on ... report on the Global Palmitic Acid industry. For ... basic information, including definition, classification, application, industry chain ... etc. , For international and China market ... in China and other countries or regions ...
(Date:11/26/2014)... MINNEAPOLIS , Nov. 25, 2014 Bio-Techne ... it has appointed Robert Gavin to serve ... of the Protein Platforms Division.  Mr. Gavin will be ... business segment, which includes the ProteinSimple business acquired in ... San Jose, California -based ProteinSimple ...
(Date:11/26/2014)... 2014  Roka Bioscience, Inc. (NASDAQ: ROKA ), ... for the detection of foodborne pathogens, today announced that ... 26 th Annual Healthcare Conference on December 2, 2014 ... New York Palace in New York, NY ... the Company, its operations, strategies and prospects may be discussed. ...
Breaking Biology Technology:SoundConnect Appoints Director of Channel Development & Sales 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2
... WYE ),announced today that it will present at ... 21, 2008 at 10:30 a.m. Eastern,Time. Presenting for Wyeth ... Officer, Wyeth., Wyeth,s presentation will be webcast live ... following the conference., Wyeth is one of the ...
... FORT WORTH, Texas, May 16 George Abercrombie, ... more than 200,Fort Worth business leaders today at ... threat of a pandemic flu presents businesses with ... "While businesses are all too familiar with ...
... Metametrix Institute (, http://www.metametrixinstitute.org ) announced ... Functional Medicine, 2nd,Edition, written and edited by Richard ... the original edition by Bralley and Lord, Laboratory,Evaluations ... is the,new educational arm of Metametrix Inc., a ...
Cached Biology Technology:CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans 2CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans 3Introducing Laboratory Evaluations for Integrative and Functional Medicine 2
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still ... Doctor McCoy used in "Star Trek" to gain instant access ... designed to work with smartphones and tablets for monitoring and ... the healthcare world. This may seem a tad Orwellian to ... to adopt some of these technological opportunities into their healthcare ...
(Date:11/10/2014)... pods began appearing on U.S. store shelves in early ... ever since. The small packets can be tossed into ... a liquid or powder. The convenience, though, has come ... from researchers at Nationwide Children,s Hospital found that from ... of 17,230 children younger than 6 years of age ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Study finds laundry detergent pods, serious poisoning risk for children 2
... Université Laval’s Faculty of Medicine have succeeded in ... from adult human skin. This is the first ... differentiation has been achieved from human skin, according ... could eventually lead to revolutionary advances in the ...
... Netherlands Institute for Sea Research obtained for the first ... over the past 25,000 years. They did this in ... Bremen, The scientists developed an entirely new method to ... molecular fossils of soil bacteria. They applied the method ...
... the adrenal gland releases cortisol to help restore the ... many and varied, lowering the activity of the immune ... learning if there's too much for too long. Given ... is essential to producing medications that can alter its ...
Cached Biology News:Scientists produce neurons from human skin 2Microfossils unravel climate history of tropical Africa 2Scientists unravel clue in cortisol production 2
... world-class performance hardware, Cerity Networked Data System ... and columns, as well as our Perfect ... you reach uncompromising results and make fast, ... Agilent 6820 GC system is not available ...
... The PolarScreen Peroxisome Proliferator-Activated ... provide a sensitive and efficient ... potential PPARGamma ligands using fluorescence ... human PPARGamma-Ligand binding domain (PPARGamma-LBD) ...
... Plus is a small and ... market for both LC and IC. It ... Atmospheric Pressure Ionization (API) source for outstanding ... is compatible with existing LC and IC ...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
Biology Products: